Close

Illumina (ILMN), Quest Diagnostics (DGX) Enter Multi-Year License for Sequencing Technology

January 9, 2014 6:31 AM EST Send to a Friend
Illumina, Inc. (Nasdaq: ILMN) announced it has entered into a multi-year licensing agreement with Quest Diagnostics (NYSE: DGX) related to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login